Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
5-MeO-MET AI simulator
(@5-MeO-MET_simulator)
Hub AI
5-MeO-MET AI simulator
(@5-MeO-MET_simulator)
5-MeO-MET
5-MeO-MET, also known as 5-methoxy-N-methyl-N-ethyltryptamine, is a serotonin receptor modulator, putative serotonergic psychedelic, and relatively rare designer drug of the tryptamine family related to psychedelic drugs like methylethyltryptamine (MET) and 5-MeO-DMT.
5-MeO-MET was not included or mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved). Relatedly, its properties, such as dose and duration, and its effects were not described.
Early studies found 5-MeO-MET to be more potent in animal behavioral tests than 5-MeO-DMT. Subsequent studies confirmed that 5-MeO-MET interacts with serotonin receptors similarly to other psychedelic tryptamines. A more modern study found that 5-MeO-MET is a potent serotonin 5-HT1A receptor ligand and serotonin 5-HT2A receptor agonist and produces the head-twitch response, a behavioral proxy of psychedelics, in rodents. Its activities were of similar potency as 5-MeO-DMT.
Analogues of 5-MeO-MET include methylethyltryptamine (MET), 4-HO-MET (metocin), 4-AcO-MET (metacetin), bretisilocin (5-fluoro-MET), 7F-5-MeO-MET, 5-MeO-DMT, 5-MeO-DET, 5-MeO-MPT, 5-MeO-EPT, 5-MeO-MALT, and 5-MeO-MiPT, among others.
5-MeO-MET was first synthesized and limitedly studied in the 1960s. The drug was first identified on the illicit market in June 2012 in Sweden. It was made illegal in Norway in 2013.
5-MeO-MET
5-MeO-MET, also known as 5-methoxy-N-methyl-N-ethyltryptamine, is a serotonin receptor modulator, putative serotonergic psychedelic, and relatively rare designer drug of the tryptamine family related to psychedelic drugs like methylethyltryptamine (MET) and 5-MeO-DMT.
5-MeO-MET was not included or mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved). Relatedly, its properties, such as dose and duration, and its effects were not described.
Early studies found 5-MeO-MET to be more potent in animal behavioral tests than 5-MeO-DMT. Subsequent studies confirmed that 5-MeO-MET interacts with serotonin receptors similarly to other psychedelic tryptamines. A more modern study found that 5-MeO-MET is a potent serotonin 5-HT1A receptor ligand and serotonin 5-HT2A receptor agonist and produces the head-twitch response, a behavioral proxy of psychedelics, in rodents. Its activities were of similar potency as 5-MeO-DMT.
Analogues of 5-MeO-MET include methylethyltryptamine (MET), 4-HO-MET (metocin), 4-AcO-MET (metacetin), bretisilocin (5-fluoro-MET), 7F-5-MeO-MET, 5-MeO-DMT, 5-MeO-DET, 5-MeO-MPT, 5-MeO-EPT, 5-MeO-MALT, and 5-MeO-MiPT, among others.
5-MeO-MET was first synthesized and limitedly studied in the 1960s. The drug was first identified on the illicit market in June 2012 in Sweden. It was made illegal in Norway in 2013.